The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project - Pagano, L.; Caira, M.; Nosari, A.; Cattaneo, C.; Fanci, R.; Bonini, A.; Vianelli, N.; Garzia, M. G.; Mancinelli, M.; Tosti, M. E.; Tumbarello, M.; Viale, P.; et al. (Haematologica (Roma), 2011)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents - therapeutic use; Antineoplastic Agents - therapeutic use; Biological and medical sciences; Female; Hematologic and hematopoietic diseases; Hematologic Neoplasms - complications; Hematologic Neoplasms - therapy; Hematopoietic Stem Cell Transplantation - adverse effects; Humans; Kaplan-Meier Estimate; Male; Medical sciences; Middle Aged; Mycoses - drug therapy; Mycoses - etiology; Mycoses - prevention & control; Neutropenia - etiology; Original; Young Adult; Hematology; Mycosis; Treatment efficiency; Malignant hemopathy; empirical antifungal therapy; Infection; Prevention; hematologic malignancies; Antifungal agent; Clinical management; Treatment; pre-emptive antifungal therapy; Comparative study; Cancer